product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Rat CD30/TNFRSF8 Fc Chimera Protein, CF
catalog :
11034-CD-100
quantity :
100 ug
price :
468 USD
more info or order :
product information
master code :
11034-CD
SKU :
11034-CD-100
product name :
Recombinant Rat CD30/TNFRSF8 Fc Chimera Protein, CF
unit size :
100 ug
description :
The Recombinant Rat CD30/TNFRSF8 Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Rat CD30/TNFRSF8 Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
CD30/TNFRSF8
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
species :
Rat
observed molecular weight :
80-95 kDa, under reducing conditions.
theoretical molecular weight :
52 kDa
details of functionality :
Measured by its binding ability in a functional ELISA. When Recombinant Mouse CD30 Ligand/TNFSF8 (Catalog # 732-CL/CF )áis immobilized at 0.250 ╡g/mL (100 ╡L/well), Recombinant Rat CD30/TNFRSF8 Mouse Fc Chimera binds with and ED50 of 20.0-120 ng/mL.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
EDL81069.1
applications :
Bioactivity
source long :
Mouse myeloma cell line, NS0-derived rat CD30/TNFRSF8 protein Rat CD30 (Phe19-Leu255) Accession # EDL81069.1 IEGRMDP Mouse IgG2a (Glu98-Lys330) N-terminus C-terminus
source short :
NS0
USD :
468 USD
alt names :
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Recombinant SARS-CoV-2 P.1.8 Spike RBD His-tag Protein, CF | 11036-CV-100
- Recombinant SARS-CoV-2 P.1.8 Spike (GCN4-IZ) His Protein, CF | 11046-CV-100
- Recombinant SARS-CoV-2 B.1.630 Spike RBD His-tag Protein, CF | 11047-CV-100
- Recombinant SARS-CoV-2 Full-length Spike Protein, CF | 11058-CV-100
- Recombinant Human Chondrolectin His-tag Protein, CF | 11059-CL-100
questions and comments